ClinicalTrials.gg
RecruitingNCT06758492NEU-VODEtecUpdated Feb 20, 2025

A Prospective Observational Study of Video Laryngoscopy Versus Direct Laryngoscopy for Insertion of a Thin Endotracheal Catheter for Surfactant Administration in Newborn Infants

An observational study in Respiratory Distress Syndrome (Neonatal), Respiratory Distress Syndrome (RDS) and Video Laryngoscopy, sponsored by University College Dublin. Recruiting at 16 sites in 9 countries. Open to participants aged 0 Minutes to 28 Days. Per ClinicalTrials.gov, last updated 2025-02-20.

Sponsored by University College Dublin · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Jan 2025; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
600
Ages
0 Minutes to 28 Days
Sex
All
01

Study summary

Many premature babies have breathing difficulty after birth and receive help with a breathing machine (nasal continuous positive airway pressure, NCPAP). Some of the babies whose breathing gets worse despite NCPAP are treated with surfactant, a medication that is given directly into their windpipe (trachea). Some of the babies who are given surfactant get it through a ventilation tube (endotracheal tube, ETT), while others get it through a thin catheter that is too small for ventilation. When doctors insert a tube or a thin catheter into the windpipe of a baby, they use an instrument called a laryngoscope, which has a light at its tip, to identify the entrance. Most often doctors look directly into the baby's mouth with a standard laryngoscope to identify the entrance to the windpipe. However, newer video laryngoscopes have a camera along with the light at their tip, which displays a picture of the entrance to the windpipe on a screen. In a study performed at one hospital, doctors inserted an ETT first time more often when they used a video laryngoscope.

The investigators are doing a study at many hospitals where doctors usually use a standard laryngoscope to insert tubes and thin catheters into a baby's trachea by looking directly into the mouth. Each hospital will switch one-by-one to using a video laryngoscope when inserting a tube. The investigators will compare the information we collect to see if more babies who have a tube inserted first time without falls in their oxygen levels or heart rate with a video laryngoscope. The investigators will also collect information on babies who have a thin catheter inserted to compare whether doctors use fewer attempts when they use a video laryngoscope.

Read the detailed description

Many newborn infants have breathing difficulty after birth, particularly when they are born prematurely. Many of these infants are supported with nasal continuous positive airway pressure (NCPAP). Some of the infants deteriorate despite treatment with NCPAP and have a thin catheter inserted into their trachea for the administration of surfactant, which is then immediately removed (often referred to as "less-invasive surfactant administration" or LISA). Insertion of a thin catheter is usually performed by doctors who are experienced at intubation (i.e. inserting endotracheal tubes, ETTs). They look directly into the the infants mouth using a standard laryngoscope to identify the opening of the airway (i.e. perform direct laryngoscopy). More recently video laryngoscopes have been developed. These devices display a magnified image of the airway on a screen that can be viewed indirectly by the doctor attempting to insert the ETT or thin catheter, and also by others. A single centre study reported that more infants were successfully intubated at the first attempt when doctors performed indirect video laryngoscopy compared to direct laryngoscopy.

It is possible to independently verify when a doctor has correctly inserted and ETT, for example by detecting carbon dioxide coming out of the tube or seeing condensation in the tube during exhalation, or by hearing breath sounds by listening to the chest during positive pressure inflations. It is not possible to independently verify whether a doctor has correctly inserted a thin catheter under direct laryngoscopy, by these or other means. The standard (and to date only) way of confirming that a thin catheter has been correctly inserted is to rely on the report of the operator. Video laryngoscopy, in contrast, allows the independent verification of the tip of a thin catheter by one or more people observing the screen.

The investigators are performing NEU-VODE, a stepped wedge cluster randomised study of the introduction of video laryngoscopy versus direct laryngoscopy for the intubation of newborn infants. Alongside this study, the investigators are performing a study of infants who have a thin endotracheal catheter inserted under video laryngoscopy versus direct laryngoscopy. As it is not possible to measure the outcome of successful insertion of the thin catheter equally in both groups, this is a prospective observational cohort study. The investigators will record information on infants who have a thin catheter inserted into the trachea for the purpose of surfactant administration at centres participating in the NEU-VODE study. The type of laryngoscope used for thin catheter insertion attempts will not be mandated; instead, the investigators will compare the information of groups within the cohort who have their first attempt made using the video laryngoscope to the group who have their first attempt made with direct laryngoscopy.

02

Conditions studied

  • Respiratory Distress Syndrome (Neonatal)
  • Respiratory Distress Syndrome (RDS)
  • Video Laryngoscopy
  • Surfactant

Keywords

  • infant, newborn
  • respiratory distress syndrome
  • surfactant
  • video laryngoscopy
03

In context

Pulmonary Atelectasis

378 studies on the registry are indexed under Pulmonary Atelectasis; 91 are open to participants now.

This study's planned enrollment of 600 is above the median of 78 across 101 observational studies indexed under Pulmonary Atelectasis.

Browse Pulmonary Atelectasis studies →

Lead sponsor

University College Dublin is the lead sponsor of 114 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Minutes to 28 Days
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Newborn infants (\<28 days old) who have a thin catheter inserted into their trachea for the purpose of surfactant administration ("less-invasive surfactant administration", LISA)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • newborn infants of any sex who are are having a thin catheter inserted into their trachea for the purpose of surfactant administration

Exclusion criteria

Exclusion Criteria:

  • no parental consent provided to share their data
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
600 participants (estimated)
Target follow-up
600 Days
Patient registry
Yes

Groups and cohorts

  • Video laryngoscopy used to insert thin endotracheal catheter

    Video laryngoscopy used to insert thin endotracheal catheter

    Device: Video laryngoscopy used to insert thin endotracheal catheter

  • Direct laryngoscopy used to insert thin endotracheal catheter

    Direct laryngoscopy used to insert thin endotracheal catheter

    Device: Direct laryngoscopy used to insert thin endotracheal catheter

Interventions

  • DeviceVideo laryngoscopy used to insert thin endotracheal catheter

    Video laryngoscopy used to insert thin endotracheal catheter

  • DeviceDirect laryngoscopy used to insert thin endotracheal catheter

    Direct laryngoscopy used to insert thin endotracheal catheter

06

What researchers measure

Primary outcomes

  1. Successful thin catheter insertion at the first attempt without physiologic instability

    Successful thin catheter insertion at the first attempt without fall in SpO2 \>20% from baseline or HR\<100bpm

    Time frame: At 30 minutes from the start of the insertion attempt

Secondary outcomes

  1. Successful thin catheter insertion at the first attempt

    Successful thin catheter insertion at the first attempt

    Time frame: At 30 minutes from the start of the insertion attempt

  2. Physiologic instability during first thin endotracheal catheter insertion attempt

    Fall in SpO2\>20% from baseline or HR\<100bpm during first thin endotracheal catheter insertion attempt

    Time frame: At 30 minutes from the start of the insertion attempt

  3. Duration of laryngoscopy of first insertion attempt

    Interval from introduction of laryngoscopy blade to its removal (seconds)

    Time frame: At 30 minutes from the start of the insertion attempt

  4. Number of attempts taken to insert thin endotracheal catheter

    Number of attempts taken to insert thin endotracheal catheter

    Time frame: At 30 minutes from the start of the insertion attempt

  5. Time taken to insert thin endotracheal catheter on successful attempt

    Interval from insertion of laryngoscope blade to insertion of thin endotracheal catheter on successful attempt (seconds)

    Time frame: At 30 minutes from the start of the insertion attempt

  6. Total laryngoscopy time to successful insertion

    Sum of all intervals from introduction of laryngoscope blade to removal for unsuccessful insertion attempts; plus interval from introduction of blade to catheter insertion for successful attempt in seconds

    Time frame: At 30 minutes from the start of the insertion attempt

  7. Lowest oxygen saturation (SpO2) during the procedure

    Lowest oxygen saturation (SpO2) during the procedure

    Time frame: At 30 minutes from the start of the insertion attempt

  8. Lowest heart rate (HR) during the procedure

    Lowest heart rate (HR) during the procedure

    Time frame: At 30 minutes from the start of the insertion attempt

  9. Oral trauma

    Oral trauma reported by clinicians

    Time frame: At 1 hour from the start of the insertion attempt

  10. Chest compressions

    Chest compressions

    Time frame: At 1 hour from the start of the insertion attempt

  11. Adrenaline

    Adrenaline

    Time frame: At 1 hour from the start of the insertion attempt

  12. Further thin catheter surfactant treatment

    Further thin catheter surfactant treatment

    Time frame: Within 72 hours of insertion attempt

  13. Endotracheal intubation and ventilation

    Endotracheal intubation and ventilation

    Time frame: Within 72 hours of insertion attempt

  14. Surfactant treatment via endotracheal tube

    Surfactant treatment via endotracheal tube

    Time frame: Within 72 hours of insertion attempt

07

Study locations

14 of 16 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Data will be shared o consideration of reasonable request to investigators

Time frame: Study publication, for 2 years

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Dec 2025, 11 months after the start.

Of 58 non-industry observational studies under Pulmonary Atelectasis, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 19. This study's planned 11 months is close to that.

Counting every sponsor, half of 58 studies reached it within 11 months; a quarter within 6 and three quarters within 19.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 20, 2024
First posted
Jan 3, 2025
StartActual
Jan 13, 2025
Primary completionEst.
Dec 13, 2025
CompletionEst.
Dec 31, 2025
Last update
Feb 20, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06758492
Responsible party
Sponsor
First posted
Jan 3, 2025
Start date
Jan 13, 2025
Primary completion
Dec 13, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Feb 20, 2025

Study contacts

Colm P.F. O'Donnell, MB PhD
Contact
codonnell@nmh.ie
+35316373100
Janneke Dekker, PhD
Contact
j.dekker@lumc.nl
Colm P.F. O'Donnell, MB PhD
principal investigator · National Maternity Hospital, Dublin, Ireland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion